Description
FUB-AMB (also known as AMB-FUBINACA and MMB-FUBINACA) is an indazole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug. It was originally developed by Pfizer which described the compound in a patent in 2009, but was later abandoned and never tested on humans.
The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.
TYPE: Cannabinoid
POWER: light | normal | strong | very strong
Systematic (IUPAC) name: methyl (2S)-2-{[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino}-3-methylbutanoate
CAS Number: 1715016-76-4
PubChem: 119026173
ChemSpider: 32741679
UNII: TY9AKI870R
Formula: C21H22FN3O3
Molar mass: 383.42 g/mol
Reviews
There are no reviews yet.